{
    "id": 29953,
    "fullName": "PSMB5 A109V",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PSMB5 A109V (corresponding to A50V in the canonical processed form) does not lie within any known functional domains of the Psmb5 protein (UniProt.org). A109V has been demonstrated to confer resistance to some proteasome inhibitors (PMID: 30954557), but has not been biochemically characterized and therefore, its effect on Psmb5 protein function is unknown (PubMed, Feb 2020).",
            "references": [
                {
                    "id": 14923,
                    "pubMedId": 30954557,
                    "title": "Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30954557"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5693,
        "geneSymbol": "PSMB5",
        "terms": [
            "PSMB5",
            "LMPX",
            "MB1",
            "X"
        ]
    },
    "variant": "A109V",
    "createDate": "04/26/2019",
    "updateDate": "02/10/2020",
    "referenceTranscriptCoordinates": {
        "id": 184079,
        "transcript": "NM_002797",
        "gDna": "chr14:g.23033547G>A",
        "cDna": "c.326C>T",
        "protein": "p.A109V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20115,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a multiple myeloma cell line demonstrated resistance to treatment with Ninlaro (ixazomib) and was subsequently found to harbor PSMB5 A109V in culture (PMID: 30954557).",
            "molecularProfile": {
                "id": 32055,
                "profileName": "PSMB5 A109V"
            },
            "therapy": {
                "id": 1359,
                "therapyName": "Ixazomib",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14923,
                    "pubMedId": 30954557,
                    "title": "Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30954557"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20118,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a multiple myeloma cell line demonstrated resistance to treatment with Velcade (bortezomib) and was subsequently found to harbor PSMB5 A109V in culture (PMID: 30954557).",
            "molecularProfile": {
                "id": 32055,
                "profileName": "PSMB5 A109V"
            },
            "therapy": {
                "id": 688,
                "therapyName": "Bortezomib",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14923,
                    "pubMedId": 30954557,
                    "title": "Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30954557"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32055,
            "profileName": "PSMB5 A109V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 184079,
            "transcript": "NM_002797",
            "gDna": "chr14:g.23033547G>A",
            "cDna": "c.326C>T",
            "protein": "p.A109V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184080,
            "transcript": "NM_001144932",
            "gDna": "chr14:g.23033547G>A",
            "cDna": "c.326C>T",
            "protein": "p.A109V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 184078,
            "transcript": "XM_005267871",
            "gDna": "chr14:g.23033547G>A",
            "cDna": "c.326C>T",
            "protein": "p.A109V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}